216 related articles for article (PubMed ID: 21082031)
21. Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas.
Ghigna C; Moroni M; Porta C; Riva S; Biamonti G
Cancer Res; 1998 Dec; 58(24):5818-24. PubMed ID: 9865741
[TBL] [Abstract][Full Text] [Related]
22. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.
Du P; Ye L; Yang Y; Jiang WG
Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253
[TBL] [Abstract][Full Text] [Related]
23. SF2 and SRp55 regulation of CD45 exon 4 skipping during T cell activation.
Lemaire R; Winne A; Sarkissian M; Lafyatis R
Eur J Immunol; 1999 Mar; 29(3):823-37. PubMed ID: 10092085
[TBL] [Abstract][Full Text] [Related]
24. SR proteins Asf/SF2 and 9G8 interact to activate enhancer-dependent intron D splicing of bovine growth hormone pre-mRNA in vitro.
Li X; Shambaugh ME; Rottman FM; Bokar JA
RNA; 2000 Dec; 6(12):1847-58. PubMed ID: 11142383
[TBL] [Abstract][Full Text] [Related]
25. Alternative splicing of iodothyronine deiodinases in pituitary adenomas. Regulation by oncoprotein SF2/ASF.
Piekielko-Witkowska A; Kedzierska H; Poplawski P; Wojcicka A; Rybicka B; Maksymowicz M; Grajkowska W; Matyja E; Mandat T; Bonicki W; Nauman P
Biochim Biophys Acta; 2013 Jun; 1832(6):763-72. PubMed ID: 23462647
[TBL] [Abstract][Full Text] [Related]
26. The splicing factor SRp20 modifies splicing of its own mRNA and ASF/SF2 antagonizes this regulation.
Jumaa H; Nielsen PJ
EMBO J; 1997 Aug; 16(16):5077-85. PubMed ID: 9305649
[TBL] [Abstract][Full Text] [Related]
27. Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors.
Hanamura A; Cáceres JF; Mayeda A; Franza BR; Krainer AR
RNA; 1998 Apr; 4(4):430-44. PubMed ID: 9630249
[TBL] [Abstract][Full Text] [Related]
28. Deregulated expression of hnRNP A/B proteins in human non-small cell lung cancer: parallel assessment of protein and mRNA levels in paired tumour/non-tumour tissues.
Boukakis G; Patrinou-Georgoula M; Lekarakou M; Valavanis C; Guialis A
BMC Cancer; 2010 Aug; 10():434. PubMed ID: 20716340
[TBL] [Abstract][Full Text] [Related]
29. The gene encoding the splicing factor SF2/ASF is a proto-oncogene.
Karni R; de Stanchina E; Lowe SW; Sinha R; Mu D; Krainer AR
Nat Struct Mol Biol; 2007 Mar; 14(3):185-93. PubMed ID: 17310252
[TBL] [Abstract][Full Text] [Related]
30. CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma.
Li T; Cheng Y; Wang P; Wang W; Hu F; Mo X; Lv H; Xu T; Han W
J Exp Clin Cancer Res; 2015 Oct; 34():122. PubMed ID: 26474560
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways.
Wang J; Manley JL
RNA; 1995 May; 1(3):335-46. PubMed ID: 7489505
[TBL] [Abstract][Full Text] [Related]
32. Genome-wide analysis of differentially expressed genes and splicing isoforms in clear cell renal cell carcinoma.
Valletti A; Gigante M; Palumbo O; Carella M; Divella C; Sbisà E; Tullo A; Picardi E; D'Erchia AM; Battaglia M; Gesualdo L; Pesole G; Ranieri E
PLoS One; 2013; 8(10):e78452. PubMed ID: 24194935
[TBL] [Abstract][Full Text] [Related]
33. Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways.
Gonçalves V; Matos P; Jordan P
Hum Mol Genet; 2009 Oct; 18(19):3696-707. PubMed ID: 19602482
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma.
Ma X; Shen D; Li H; Zhang Y; Lv X; Huang Q; Gao Y; Li X; Gu L; Xiu S; Bao X; Duan J; Zhang X
Urol Oncol; 2015 Apr; 33(4):169.e1-11. PubMed ID: 25700976
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of miR-181a in clear cell renal cell carcinoma is associated with lower KLF6 expression, enhanced cell proliferation, accelerated cell cycle transition, and diminished apoptosis.
Lei Z; Ma X; Li H; Zhang Y; Gao Y; Fan Y; Li X; Chen L; Xie Y; Chen J; Wu S; Tang L; Zhang X
Urol Oncol; 2018 Mar; 36(3):93.e23-93.e37. PubMed ID: 29066014
[TBL] [Abstract][Full Text] [Related]
37. General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer.
Sun Q; Mayeda A; Hampson RK; Krainer AR; Rottman FM
Genes Dev; 1993 Dec; 7(12B):2598-608. PubMed ID: 8276242
[TBL] [Abstract][Full Text] [Related]
38. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors.
Cáceres JF; Stamm S; Helfman DM; Krainer AR
Science; 1994 Sep; 265(5179):1706-9. PubMed ID: 8085156
[TBL] [Abstract][Full Text] [Related]
39. Expression of miRNA-21 and miRNA-221 in clear cell renal cell carcinoma (ccRCC) and their possible role in the development of ccRCC.
Szabó Z; Szegedi K; Gombos K; Mahua C; Flaskó T; Harda K; Halmos G
Urol Oncol; 2016 Dec; 34(12):533.e21-533.e27. PubMed ID: 27427222
[TBL] [Abstract][Full Text] [Related]
40. Regulation of Ich-1 pre-mRNA alternative splicing and apoptosis by mammalian splicing factors.
Jiang ZH; Zhang WJ; Rao Y; Wu JY
Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9155-60. PubMed ID: 9689050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
